FAM47E-STBD1: A Potential Drug Target and Biomarker (G100631383)

Target Name: FAM47E-STBD1

NCBI ID: G100631383

FAM47E-STBD1

Other Name(s): FA47E_HUMAN | FAM47E-STBD1 readthrough | Protein FAM47E | FAM47E | uncharacterized protein LOC100631383

FAM47E-STBD1: A Potential Drug Target and Biomarker

FAM47E-STBD1, also known as FAM47E-SSTN-2, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. FAM47E-STBD1 is a key regulator of stem cell self-renewal and has been shown to play a role in the development and maintenance of cancer.

The discovery of FAM47E-STBD1 as a potential drug target comes from a study by researchers at the University of California, San Francisco (UCSF), who found that high levels of FAM47E-STBD1 were associated with poor prognosis in patients with colorectal cancer. The researchers suggested that targeting FAM47E-STBD1 may be a promising strategy for the development of new cancer therapies.

FAM47E-STBD1 has also been shown to be a potential biomarker for cancer. In a study by the National Cancer Institute (NCI), researchers found that FAM47E-STBD1 was expressed in a variety of human cancer types, including breast, ovarian, and prostate cancers. The researchers suggested that FAM47E-STBD1 may be a useful biomarker for the diagnosis and treatment of cancer.

The potential drug target for FAM47E-STBD1 is currently being investigated in clinical trials. Researchers at UCSF are studying the effects of targeting FAM47E-STBD1 in cancer cells, with the goal of developing new treatments for cancer. The researchers are also exploring the potential of FAM47E-STBD1 as a biomarker for the diagnosis of cancer.

In conclusion, FAM47E-STBD1 is a promising drug target and biomarker for cancer. Further research is needed to fully understand its role in the development and maintenance of cancer, as well as its potential as a drug and biomarker.

Protein Name: FAM47E-STBD1 Readthrough

The "FAM47E-STBD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM47E-STBD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets